The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 13, 2011
Filed:
May. 08, 2007
Caroline Ericsson, Eslov, SE;
Martin Bohlin, Sodertalje, SE;
Tesfai Sebhatu, Sodedrtalje, SE;
Gary M. Dull, Lewisville, NC (US);
Julio A. Munoz, Walnut Cove, NC (US);
Craig H. Miller, Winston-Salem, NC (US);
Caroline Ericsson, Eslov, SE;
Martin Bohlin, Sodertalje, SE;
Tesfai Sebhatu, Sodedrtalje, SE;
Gary M. Dull, Lewisville, NC (US);
Julio A. Munoz, Walnut Cove, NC (US);
Craig H. Miller, Winston-Salem, NC (US);
AstraZeneca AB, Sodertalje, SE;
Targacept, Inc., Winston-Salem, NC (US);
Abstract
Phosphoric acid, edisylic acid (1,2-ethanedisulfonic acid), citric acid, orotic acid (uracil-6-carboxylic acid), R-mandelic acid, sulfuric acid, 1,5-naphthalenedisulfonic acid, D-aspartic acid, and lysine monohydrochloride salts of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine, and methods for their preparation, pharmaceutical compositions comprising said salts, and use, are disclosed. The salts can be administered to patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, to treat and/or prevent such disorders.